- Details
Novartis reports that profits fell 42% due largely to weak performance by its eye care division, Alcon.
- Details
The FDA has approved Zeimer’s femtosecond laser device
Read more: FDA approves laser for refractive and cataract surgery
- Details
The FDA has approved Zeimer’s femtosecond laser device.
Read more: FDA approves laser for refractive and cataract surgery
- Details
Shire announced that lifitegrast met its primary and secondary endpoints
- Details
Investigators found that the latest concept in the prevention of post-cataract posterior capsule opacification appears promising.
Read more: Protective membrane shows promise in reducing PCO
- Details
Adherence patterns established during the first year of treatment typically don’t change over time.
Read more: Glaucoma medication adherence: Early habits stick